A randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of dupilumab in children 6 to <12 years of age with uncontrolled persistent asthma STUDY NUMBER: EFC14153

Administered By

Awarded By

Contributors

Start/End

  • October 25, 2017 - September 30, 2019